Subcutaneous injection containing IL-3 and GM-CSF ameliorates stab wound-induced brain injury in rats

Experimental Neurology

Volumn 229, Issue 2, 2011, Pages 507-516

  Nishihara, Tasuku ^a,b   Ochi, Michihisa ^a,b   Sugimoto, Kana ^a,b   Takahashi, Hisaaki ^a,b   Yano, Hajime ^a,b   Kumon, Yoshiaki ^a,b   Ohnishi, Takanori ^a,b   Tanaka, Junya ^a,b  

^a EHIME UNIVERSITY   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

GM CSF; Iba1; IL 3; Macrophage; NG2; Subcutaneous injection; Traumatic brain injury

Indexed keywords

CELL PROTEIN; CYCLINE; FLUOROURACIL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 3 RECEPTOR; MESSENGER RNA; PROTEIN IBA1; PROTEIN NG2; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 3; SCATTER FACTOR; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; IN VITRO STUDY; MACROPHAGE; MALE; MORTALITY; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; STAB WOUND; TRAUMATIC BRAIN INJURY; WOUND HEALING;

ANIMALS; BRAIN INJURIES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEPATOCYTE GROWTH FACTOR; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-3; MACROPHAGES; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RNA, MESSENGER; TREATMENT OUTCOME; WOUND HEALING;

EID: 79956081867     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.04.006     Document Type: Article

References (30)

1. Antman K.H. G-CSF and GM-CSF in clinical trials. Yale J. Biol. Med. 1990, 63:387-410.
2. Barreda D.R., Hanington P.C., Belosevic M. Regulation of myeloid development and function by colony stimulating factors. Dev. Comp. Immunol. 2004, 28:509-554.
3. Beer R., Franz G., Krajewski S., Pike B.R., Hayes R.L., Reed J.C., Wang K.K., Klimmer C., Schmutzhard E., Poewe W., Kampfl A. Temporal and spatial profile of caspase 8 expression and proteolysis after experimental traumatic brain injury. J. Neurochem. 2001, 78:862-873.
4. Berezovskaya O., Maysinger D., Fedoroff S. Colony stimulating factor-1 potentiates neuronal survival in cerebral cortex ischemic lesion. Acta Neuropathol. 1996, 92:479-486.
5. Bethel A., Kirsch J.R., Koehler R.C., Finklestein S.P., Traystman R.J. Intravenous basic fibroblast growth factor decreases brain injury resulting from focal ischemia in cats. Stroke 1997, 28:609-615. discussion 615-606.
6. Bigler E.D., Kurth S., Blatter D., Abildskov T. Day-of-injury CT as an index to pre-injury brain morphology: degree of post-injury degenerative changes identified by CT and MR neuroimaging. Brain Inj. 1993, 7:125-134.
7. Cheng B., Mattson M.P. NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron 1991, 7:1031-1041.
8. Gibson C.L., Gray L.J., Bath P.M., Murphy S.P. Progesterone for the treatment of experimental brain injury; a systematic review. Brain 2008, 131:318-328.
9. Immonen R.J., Kharatishvili I., Niskanen J.P., Grohn H., Pitkanen A., Grohn O.H. Distinct MRI pattern in lesional and perilesional area after traumatic brain injury in rat-11months follow-up. Exp. Neurol. 2009, 215:29-40.
10. Mammis A., McIntosh T.K., Maniker A.H. Erythropoietin as a neuroprotective agent in traumatic brain injury review. Surg. Neurol. 2009, 71:527-531. discussion 531.
11. Matsumoto H., Kumon Y., Watanabe H., Ohnishi T., Shudou M., Ii C., Takahashi H., Imai Y., Tanaka J. Antibodies to CD11b, CD68, and lectin label neutrophils rather than microglia in traumatic and ischemic brain lesions. J. Neurosci. Res. 2007, 85:994-1009.
12. Matsumoto H., Kumon Y., Watanabe H., Ohnishi T., Shudou M., Chuai M., Imai Y., Takahashi H., Tanaka J. Accumulation of macrophage-like cells expressing NG2 proteoglycan and Iba1 in ischemic core of rat brain after transient middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 2008, 28:149-163.
13. Mazzeo A.T., Beat A., Singh A., Bullock M.R. The role of mitochondrial transition pore, and its modulation, in traumatic brain injury and delayed neurodegeneration after TBI. Exp. Neurol. 2009, 218:363-370.
14. Minambres E., Ballesteros M.A., Mayorga M., Marin M.J., Munoz P., Figols J., Lopez-Hoyos M. Cerebral apoptosis in severe traumatic brain injury patients: an in vitro, in vivo, and postmortem study. J. Neurotrauma 2008, 25:581-591.
15. Nakano-Doi A., Nakagomi T., Fujikawa M., Nakagomi N., Kubo S., Lu S., Yoshikawa H., Soma T., Taguchi A., Matsuyama T. Bone marrow mononuclear cells promote proliferation of endogenous neural stem cells through vascular niches after cerebral infarction. Stem Cells 2010, 28:1292-1302.
16. Newcomb J.K., Zhao X., Pike B.R., Hayes R.L. Temporal profile of apoptotic-like changes in neurons and astrocytes following controlled cortical impact injury in the rat. Exp. Neurol. 1999, 158:76-88.
17. Peng H., Wen T.C., Tanaka J., Maeda N., Matsuda S., Desaki J., Sudo S., Zhang B., Sakanaka M. Epidermal growth factor protects neuronal cells in vivo and in vitro against transient forebrain ischemia- and free radical-induced injuries. J. Cereb. Blood Flow Metab. 1998, 18:349-360.
18. Raivich G., Haas S., Werner A., Klein M.A., Kloss C., Kreutzberg G.W. Regulation of MCSF receptors on microglia in the normal and injured mouse central nervous system: a quantitative immunofluorescence study using confocal laser microscopy. J. Comp. Neurol. 1998, 395:342-358.
19. Sahuquillo J., Arikan F. Decompressive craniectomy for the treatment of refractory high intracranial pressure in traumatic brain injury. Cochrane Database Syst. Rev. 2006, CD003983.
20. Sayeed I., Stein D.G. Progesterone as a neuroprotective factor in traumatic and ischemic brain injury. Prog. Brain Res. 2009, 175:219-237.
21. Schabitz W.R., Kruger C., Pitzer C., Weber D., Laage R., Gassler N., Aronowski J., Mier W., Kirsch F., Dittgen T., Bach A., Sommer C., Schneider A. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF). J. Cereb. Blood Flow Metab. 2008, 28:29-43.
22. Sen A.P., Gulati A. Use of magnesium in traumatic brain injury. Neurotherapeutics 2010, 7:91-99.
23. Smirkin A., Matsumoto H., Takahashi H., Inoue A., Tagawa M., Ohue S., Watanabe H., Yano H., Kumon Y., Ohnishi T., Tanaka J. Iba1(+)/NG2(+) macrophage-like cells expressing a variety of neuroprotective factors ameliorate ischemic damage of the brain. J. Cereb. Blood Flow Metab. 2010, 30:603-615.
24. Tanaka J., Toku K., Matsuda S., Sudo S., Fujita H., Sakanaka M., Maeda N. Induction of resting microglia in culture medium devoid of glycine and serine. Glia 1998, 24:198-215.
25. Toth Z.E., Leker R.R., Shahar T., Pastorino S., Szalayova I., Asemenew B., Key S., Parmelee A., Mayer B., Nemeth K., Bratincsak A., Mezey E. The combination of granulocyte colony-stimulating factor and stem cell factor significantly increases the number of bone marrow-derived endothelial cells in brains of mice following cerebral ischemia. Blood 2008, 111:5544-5552.
26. Utagawa A., Truettner J.S., Dietrich W.D., Bramlett H.M. Systemic inflammation exacerbates behavioral and histopathological consequences of isolated traumatic brain injury in rats. Exp. Neurol. 2008, 211:283-291.
27. Vink R., Van Den Heuvel C. Recent advances in the development of multifactorial therapies for the treatment of traumatic brain injury. Expert Opin. Investig. Drugs 2004, 13:1263-1274.
28. Wen T.C., Tanaka J., Peng H., Desaki J., Matsuda S., Maeda N., Fujita H., Sato K., Sakanaka M. Interleukin 3 prevents delayed neuronal death in the hippocampal CA1 field. J. Exp. Med. 1998, 188:635-649.
29. Yokoyama A., Sakamoto A., Kameda K., Imai Y., Tanaka J. NG2 proteoglycan-expressing microglia as multipotent neural progenitors in normal and pathologic brains. Glia 2006, 53:754-768.
30. Zhao L.R., Singhal S., Duan W.M., Mehta J., Kessler J.A. Brain repair by hematopoietic growth factors in a rat model of stroke. Stroke 2007, 38:2584-2591.